Clovoxamine, with the CAS number 54739-19-4, is a chemical compound classified as a selective serotonin reuptake inhibitor (SSRI). It is primarily used in the treatment of obsessive-compulsive disorder (OCD) and other anxiety-related conditions. Clovoxamine functions by increasing the levels of serotonin in the brain, which helps to improve mood and reduce anxiety. The compound is characterized by its ability to selectively inhibit the reuptake of serotonin at the synaptic cleft, thereby enhancing serotonergic neurotransmission. Clovoxamine is typically administered in oral form and may exhibit a range of pharmacokinetic properties, including absorption, distribution, metabolism, and excretion that can vary among individuals. Common side effects may include nausea, drowsiness, and dry mouth, among others. As with other SSRIs, it is important for patients to be monitored for potential side effects and interactions with other medications. Overall, Clovoxamine represents a significant therapeutic option in the management of certain psychiatric disorders.

Clovoxamine

54739-19-4: (1E)-1-(4-chlorophenyl)-5-methoxypentan-1-one O-(2-aminoethyl)oxime, (E)-1-(4-Chlorophenyl)-5-methoxy-1-pentanone O-(2-aminoethyl)oxime, 1-Pentanone, 1-(4-chlorophenyl)-5-methoxy-, O-(2-aminoethyl)oxime, (1E)-, 1-Pentanone, 1-(4-chlorophenyl)-5-methoxy-, O-(2-aminoethyl)oxime, (E)-, 4'-Chloro-5-methoxyvalerophenone (E)-O-(2-aminoethyl)oxime, Clovoxamina, Clovoxamina [INN-Spanish], Clovoxamina [Spanish], Clovoxamine [INN], Clovoxaminum, Clovoxaminum [INN-Latin], Du 23811, Unii-7I22J7Ry2A, p-Chloro-5-methoxyvalerophenone (E)-O-(2-aminoethyl)oxime, Clovoxamine

Clovoxamine fumarate (DU 23811 fumarate) is a 5-HT reuptake, serotonin and norepinephrine inhibitor with antidepressant and anticonvulsant activity.

CAS 54739-19-4: Clovoxamine

Clovoxamine

Ref: TM-T27047

Clovoxamine

Ref: 54-BUP03483